919 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Friday’s Close
TEVA Teva Pharmaceutical Industries Limited $23.43 $23.86B N/A
Article Searches
Teva to seek growth beyond $40.5B Allergan deal, CEO says; buys Allergan U.S. distribution unit for $500M http://seekingalpha.com/news/3199288-teva-seek-growth-beyond-40_5b-allergan-deal-ceo-says-buys-allergan-u-s-distribution-unit-500m?source=feed_news_all Aug 03, 2016 - Teva Pharmaceutical ([[TEVA]] +1%) CEO Erex Vigodman tells Bloomberg that the completion of its $40.5B purchase of Allergan's ([[AGN]] +1.6%) generics unit
5 Drug Stocks to Watch for Earnings on Aug 4: BMRN & More http://www.zacks.com/stock/news/226539/5-drug-stocks-to-watch-for-earnings-on-aug-4-bmrn-more?cid=CS-ZC-FT-226539 Aug 03, 2016 - How will drug stocks like BMRN, TEVA, REGN and others, scheduled to report on Aug 4, fare this earnings season?
Teva (TEVA): Stock Likely to Beat on Earnings in Q2 Again? http://www.zacks.com/stock/news/226197/teva-teva-stock-likely-to-beat-on-earnings-in-q2-again?cid=CS-ZC-FT-226197 Aug 02, 2016 - Our proven model shows that Teva (TEVA) is likely to beat earnings this quarter because it has the right combination of two key ingredients.
U.S. FTC blesses Teva purchase of Actavis Generics http://seekingalpha.com/news/3196563-u-s-ftc-blesses-teva-purchase-actavis-generics?source=feed_news_all Jul 27, 2016 - The U.S. Federal Trade Commission ((FTC)) accepts the proposed consent order related to Teva Pharmaceutical Industries' ([[TEVA]] +1.4%) acquisition of Act
Teva Growth Stock http://seekingalpha.com/article/3991944-teva-growth-stock?source=feed_tag_israel Jul 27, 2016 - Teva Pharmaceuticals is rapidly expanding on multiple fronts.Huge inroads are in progress to the 115+ billion dollar sales per year Japanese pharmaceutical markets.Latest update on huge 40.5 billion d
Teva prices €4B debt offering http://seekingalpha.com/news/3194652-teva-prices-4b-debt-offering?source=feed_news_all Jul 21, 2016 - Teva Pharmaceutical Industries (TEVA) prices a €4B offering of senior notes. The three tranches are: €1.75B of 0.375% fixed rate senior notes due 2020: 99.
Teva prices notes to fund Allergan deal http://seekingalpha.com/news/3193862-teva-prices-notes-fund-allergan-deal?source=feed_news_all Jul 19, 2016 - Teva Pharmaceutical (TEVA) has successfully priced a debt offering for $15M worth of senior notes, maturing between 2018 and 2046, to help fund its acquisi
Allergan's Teva Update: Relax http://seekingalpha.com/article/3988443-allergans-teva-update-relax?source=feed_sector_healthcare Jul 14, 2016 - Allergan's sale of its generic business to Teva is proceeding.Closing the Teva transaction should be a major catalyst for Allergan shares.Capital allocation plan balances M&A flexibility, debt pay dow
Company News for July 14, 2016 http://www.zacks.com/stock/news/223465/company-news-for-july-14-2016?cid=CS-ZC-FT-223465 Jul 14, 2016 - Companies In The News are: VRX,TEVA,NOK,HCSG
Teva (TEVA) Provides 2016-2019 Outlook, Shares Gain http://www.zacks.com/stock/news/223394/teva-teva-provides-2016-2019-outlook-shares-gain?cid=CS-ZC-FT-223394 Jul 14, 2016 - Teva (TEVA) provided its preliminary outlook for 2016-2019 and expects the Actavis Generics acquisition to go through anytime soon.

Pages: 1...848586878889909192

<<<Page 89>